nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—HTR1D—meninx—peripheral nervous system neoplasm	0.0475	0.124	CbGeAlD
Apomorphine—HTR1B—dura mater—peripheral nervous system neoplasm	0.0451	0.118	CbGeAlD
Apomorphine—HTR1D—dura mater—peripheral nervous system neoplasm	0.0437	0.114	CbGeAlD
Apomorphine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0255	0.0666	CbGeAlD
Apomorphine—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.0194	0.0506	CbGeAlD
Apomorphine—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.0188	0.049	CbGeAlD
Apomorphine—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.0138	0.0361	CbGeAlD
Apomorphine—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.0134	0.0349	CbGeAlD
Apomorphine—DRD5—ganglion—peripheral nervous system neoplasm	0.0113	0.0295	CbGeAlD
Apomorphine—CALY—trigeminal ganglion—peripheral nervous system neoplasm	0.011	0.0286	CbGeAlD
Apomorphine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00933	0.0243	CbGeAlD
Apomorphine—DRD1—nerve—peripheral nervous system neoplasm	0.00875	0.0228	CbGeAlD
Apomorphine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00873	0.0228	CbGeAlD
Apomorphine—DRD1—ganglion—peripheral nervous system neoplasm	0.00864	0.0225	CbGeAlD
Apomorphine—HTR1B—ganglion—peripheral nervous system neoplasm	0.007	0.0183	CbGeAlD
Apomorphine—HTR1D—ganglion—peripheral nervous system neoplasm	0.00678	0.0177	CbGeAlD
Apomorphine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00671	0.0175	CbGeAlD
Apomorphine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00665	0.0173	CbGeAlD
Apomorphine—HTR2A—pons—peripheral nervous system neoplasm	0.00657	0.0171	CbGeAlD
Apomorphine—HTR1A—ganglion—peripheral nervous system neoplasm	0.00565	0.0147	CbGeAlD
Apomorphine—DRD2—nerve—peripheral nervous system neoplasm	0.00517	0.0135	CbGeAlD
Apomorphine—DRD2—ganglion—peripheral nervous system neoplasm	0.0051	0.0133	CbGeAlD
Apomorphine—CALY—cerebellum—peripheral nervous system neoplasm	0.00479	0.0125	CbGeAlD
Apomorphine—DRD1—brainstem—peripheral nervous system neoplasm	0.00376	0.00979	CbGeAlD
Apomorphine—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00344	0.00897	CbGeAlD
Apomorphine—HTR2A—nerve—peripheral nervous system neoplasm	0.00341	0.00889	CbGeAlD
Apomorphine—HTR2A—ganglion—peripheral nervous system neoplasm	0.00337	0.00878	CbGeAlD
Apomorphine—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00333	0.00868	CbGeAlD
Apomorphine—HTR1B—brainstem—peripheral nervous system neoplasm	0.00304	0.00794	CbGeAlD
Apomorphine—HTR1D—brainstem—peripheral nervous system neoplasm	0.00295	0.00768	CbGeAlD
Apomorphine—HTR2C—brainstem—peripheral nervous system neoplasm	0.00292	0.00761	CbGeAlD
Apomorphine—HTR1A—brainstem—peripheral nervous system neoplasm	0.00246	0.0064	CbGeAlD
Apomorphine—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.00244	0.00636	CbGeAlD
Apomorphine—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.0023	0.006	CbGeAlD
Apomorphine—Mental disorder—Tretinoin—peripheral nervous system neoplasm	0.00224	0.00475	CcSEcCtD
Apomorphine—Dehydration—Cisplatin—peripheral nervous system neoplasm	0.00222	0.0047	CcSEcCtD
Apomorphine—DRD2—brainstem—peripheral nervous system neoplasm	0.00222	0.00579	CbGeAlD
Apomorphine—Orthostatic hypotension—Cisplatin—peripheral nervous system neoplasm	0.00218	0.00462	CcSEcCtD
Apomorphine—Pneumonia—Alitretinoin—peripheral nervous system neoplasm	0.00217	0.0046	CcSEcCtD
Apomorphine—Back pain—Topotecan—peripheral nervous system neoplasm	0.00217	0.0046	CcSEcCtD
Apomorphine—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00216	0.00457	CcSEcCtD
Apomorphine—Back pain—Tretinoin—peripheral nervous system neoplasm	0.00216	0.00456	CcSEcCtD
Apomorphine—Back pain—Isotretinoin—peripheral nervous system neoplasm	0.00216	0.00456	CcSEcCtD
Apomorphine—Nasopharyngitis—Cisplatin—peripheral nervous system neoplasm	0.00214	0.00452	CcSEcCtD
Apomorphine—Urinary tract infection—Alitretinoin—peripheral nervous system neoplasm	0.0021	0.00444	CcSEcCtD
Apomorphine—Pneumonia—Vincristine—peripheral nervous system neoplasm	0.00209	0.00443	CcSEcCtD
Apomorphine—Sweating increased—Cisplatin—peripheral nervous system neoplasm	0.00201	0.00426	CcSEcCtD
Apomorphine—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.002	0.00423	CcSEcCtD
Apomorphine—Syncope—Tretinoin—peripheral nervous system neoplasm	0.002	0.00423	CcSEcCtD
Apomorphine—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.00196	0.00414	CcSEcCtD
Apomorphine—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.00196	0.00414	CcSEcCtD
Apomorphine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00194	0.00507	CbGeAlD
Apomorphine—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.00194	0.00411	CcSEcCtD
Apomorphine—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.00193	0.00408	CcSEcCtD
Apomorphine—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.00191	0.00405	CcSEcCtD
Apomorphine—Chest pain—Topotecan—peripheral nervous system neoplasm	0.00191	0.00405	CcSEcCtD
Apomorphine—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.0019	0.00401	CcSEcCtD
Apomorphine—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.0019	0.00401	CcSEcCtD
Apomorphine—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.0019	0.00401	CcSEcCtD
Apomorphine—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.0019	0.00401	CcSEcCtD
Apomorphine—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.00189	0.004	CcSEcCtD
Apomorphine—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.00189	0.004	CcSEcCtD
Apomorphine—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00187	0.00396	CcSEcCtD
Apomorphine—Hallucination—Vincristine—peripheral nervous system neoplasm	0.00186	0.00394	CcSEcCtD
Apomorphine—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.00184	0.0039	CcSEcCtD
Apomorphine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00183	0.00388	CcSEcCtD
Apomorphine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00183	0.00388	CcSEcCtD
Apomorphine—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00182	0.00385	CcSEcCtD
Apomorphine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00182	0.00385	CcSEcCtD
Apomorphine—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.0018	0.00381	CcSEcCtD
Apomorphine—Dyskinesia—Epirubicin—peripheral nervous system neoplasm	0.0018	0.00381	CcSEcCtD
Apomorphine—Oedema—Melphalan—peripheral nervous system neoplasm	0.0018	0.0038	CcSEcCtD
Apomorphine—Shock—Tretinoin—peripheral nervous system neoplasm	0.00179	0.00379	CcSEcCtD
Apomorphine—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00179	0.00379	CcSEcCtD
Apomorphine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00177	0.00375	CcSEcCtD
Apomorphine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00176	0.00372	CcSEcCtD
Apomorphine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00176	0.00372	CcSEcCtD
Apomorphine—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.0036	CcSEcCtD
Apomorphine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.0017	0.0036	CcSEcCtD
Apomorphine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.0017	0.0036	CcSEcCtD
Apomorphine—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.0017	0.00359	CcSEcCtD
Apomorphine—Injection site reaction—Epirubicin—peripheral nervous system neoplasm	0.00168	0.00356	CcSEcCtD
Apomorphine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00168	0.00355	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00167	0.00353	CcSEcCtD
Apomorphine—Dyskinesia—Doxorubicin—peripheral nervous system neoplasm	0.00166	0.00352	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00166	0.00351	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00166	0.00351	CcSEcCtD
Apomorphine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00165	0.00348	CcSEcCtD
Apomorphine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00165	0.00348	CcSEcCtD
Apomorphine—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.00164	0.00347	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00164	0.00346	CcSEcCtD
Apomorphine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00163	0.00346	CcSEcCtD
Apomorphine—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.00163	0.00346	CcSEcCtD
Apomorphine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00162	0.00343	CcSEcCtD
Apomorphine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00162	0.00343	CcSEcCtD
Apomorphine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00162	0.00342	CcSEcCtD
Apomorphine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00162	0.00342	CcSEcCtD
Apomorphine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.0016	0.00339	CcSEcCtD
Apomorphine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00158	0.00334	CcSEcCtD
Apomorphine—Back pain—Vincristine—peripheral nervous system neoplasm	0.00157	0.00333	CcSEcCtD
Apomorphine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00157	0.00332	CcSEcCtD
Apomorphine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00157	0.00332	CcSEcCtD
Apomorphine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00157	0.00332	CcSEcCtD
Apomorphine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00329	CcSEcCtD
Apomorphine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00329	CcSEcCtD
Apomorphine—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.00155	0.00329	CcSEcCtD
Apomorphine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00155	0.00327	CcSEcCtD
Apomorphine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00153	0.00325	CcSEcCtD
Apomorphine—Ecchymosis—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00323	CcSEcCtD
Apomorphine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.0032	CcSEcCtD
Apomorphine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00151	0.0032	CcSEcCtD
Apomorphine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.0015	0.00317	CcSEcCtD
Apomorphine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.0015	0.00317	CcSEcCtD
Apomorphine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00149	0.00315	CcSEcCtD
Apomorphine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00148	0.00314	CcSEcCtD
Apomorphine—HTR2A—brainstem—peripheral nervous system neoplasm	0.00146	0.00382	CbGeAlD
Apomorphine—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00304	CcSEcCtD
Apomorphine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00304	CcSEcCtD
Apomorphine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00303	CcSEcCtD
Apomorphine—Ecchymosis—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00299	CcSEcCtD
Apomorphine—Flushing—Etoposide—peripheral nervous system neoplasm	0.00141	0.00297	CcSEcCtD
Apomorphine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00294	CcSEcCtD
Apomorphine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00292	CcSEcCtD
Apomorphine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00287	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00135	0.00287	CcSEcCtD
Apomorphine—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00286	CcSEcCtD
Apomorphine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.00282	CcSEcCtD
Apomorphine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00133	0.00281	CcSEcCtD
Apomorphine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00132	0.00278	CcSEcCtD
Apomorphine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0013	0.00276	CcSEcCtD
Apomorphine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0013	0.00276	CcSEcCtD
Apomorphine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.0013	0.00274	CcSEcCtD
Apomorphine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00129	0.00273	CcSEcCtD
Apomorphine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00129	0.00273	CcSEcCtD
Apomorphine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00129	0.00272	CcSEcCtD
Apomorphine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00129	0.00272	CcSEcCtD
Apomorphine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00128	0.00272	CcSEcCtD
Apomorphine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00128	0.00271	CcSEcCtD
Apomorphine—Back pain—Etoposide—peripheral nervous system neoplasm	0.00128	0.0027	CcSEcCtD
Apomorphine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00127	0.00269	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00266	CcSEcCtD
Apomorphine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00125	0.00265	CcSEcCtD
Apomorphine—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00265	CcSEcCtD
Apomorphine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00264	CcSEcCtD
Apomorphine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00124	0.00263	CcSEcCtD
Apomorphine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00124	0.00263	CcSEcCtD
Apomorphine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00124	0.00263	CcSEcCtD
Apomorphine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.0026	CcSEcCtD
Apomorphine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00123	0.0026	CcSEcCtD
Apomorphine—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.00123	0.0026	CcSEcCtD
Apomorphine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00259	CcSEcCtD
Apomorphine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00123	0.00259	CcSEcCtD
Apomorphine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00258	CcSEcCtD
Apomorphine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00121	0.00257	CcSEcCtD
Apomorphine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.00121	0.00316	CbGeAlD
Apomorphine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00121	0.00256	CcSEcCtD
Apomorphine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0012	0.00254	CcSEcCtD
Apomorphine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.00254	CcSEcCtD
Apomorphine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.0012	0.00254	CcSEcCtD
Apomorphine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00251	CcSEcCtD
Apomorphine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00249	CcSEcCtD
Apomorphine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00248	CcSEcCtD
Apomorphine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00117	0.00247	CcSEcCtD
Apomorphine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00116	0.00245	CcSEcCtD
Apomorphine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00116	0.00245	CcSEcCtD
Apomorphine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.00245	CcSEcCtD
Apomorphine—Headache—Topotecan—peripheral nervous system neoplasm	0.00115	0.00243	CcSEcCtD
Apomorphine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00115	0.00242	CcSEcCtD
Apomorphine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00114	0.00242	CcSEcCtD
Apomorphine—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00241	CcSEcCtD
Apomorphine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00241	CcSEcCtD
Apomorphine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00241	CcSEcCtD
Apomorphine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.0024	CcSEcCtD
Apomorphine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00114	0.0024	CcSEcCtD
Apomorphine—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.0024	CcSEcCtD
Apomorphine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00114	0.0024	CcSEcCtD
Apomorphine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00112	0.00237	CcSEcCtD
Apomorphine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00237	CcSEcCtD
Apomorphine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0011	0.00232	CcSEcCtD
Apomorphine—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.0011	0.00232	CcSEcCtD
Apomorphine—DRD2—cerebellum—peripheral nervous system neoplasm	0.00109	0.00285	CbGeAlD
Apomorphine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00109	0.0023	CcSEcCtD
Apomorphine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00108	0.0023	CcSEcCtD
Apomorphine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00229	CcSEcCtD
Apomorphine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00229	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00226	CcSEcCtD
Apomorphine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00226	CcSEcCtD
Apomorphine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00107	0.00226	CcSEcCtD
Apomorphine—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.00106	0.00277	CbGeAlD
Apomorphine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00223	CcSEcCtD
Apomorphine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00222	CcSEcCtD
Apomorphine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00104	0.0022	CcSEcCtD
Apomorphine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00219	CcSEcCtD
Apomorphine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00219	CcSEcCtD
Apomorphine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00215	CcSEcCtD
Apomorphine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00215	CcSEcCtD
Apomorphine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00101	0.00213	CcSEcCtD
Apomorphine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000989	0.00209	CcSEcCtD
Apomorphine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000975	0.00206	CcSEcCtD
Apomorphine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000968	0.00205	CcSEcCtD
Apomorphine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000959	0.00203	CcSEcCtD
Apomorphine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000957	0.00202	CcSEcCtD
Apomorphine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000956	0.00202	CcSEcCtD
Apomorphine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000953	0.00202	CcSEcCtD
Apomorphine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000951	0.00201	CcSEcCtD
Apomorphine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000946	0.002	CcSEcCtD
Apomorphine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000945	0.002	CcSEcCtD
Apomorphine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000943	0.002	CcSEcCtD
Apomorphine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000928	0.00196	CcSEcCtD
Apomorphine—Constipation—Etoposide—peripheral nervous system neoplasm	0.00092	0.00195	CcSEcCtD
Apomorphine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000919	0.00194	CcSEcCtD
Apomorphine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000911	0.00193	CcSEcCtD
Apomorphine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000909	0.00192	CcSEcCtD
Apomorphine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000887	0.00188	CcSEcCtD
Apomorphine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000883	0.00187	CcSEcCtD
Apomorphine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00088	0.00186	CcSEcCtD
Apomorphine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000878	0.00186	CcSEcCtD
Apomorphine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000876	0.00185	CcSEcCtD
Apomorphine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000875	0.00185	CcSEcCtD
Apomorphine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000864	0.00183	CcSEcCtD
Apomorphine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000851	0.0018	CcSEcCtD
Apomorphine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000849	0.00221	CbGeAlD
Apomorphine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000844	0.00179	CcSEcCtD
Apomorphine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000843	0.00178	CcSEcCtD
Apomorphine—Headache—Vincristine—peripheral nervous system neoplasm	0.000832	0.00176	CcSEcCtD
Apomorphine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000819	0.00173	CcSEcCtD
Apomorphine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000804	0.0017	CcSEcCtD
Apomorphine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000789	0.00167	CcSEcCtD
Apomorphine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000788	0.00167	CcSEcCtD
Apomorphine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000772	0.00163	CcSEcCtD
Apomorphine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000761	0.00161	CcSEcCtD
Apomorphine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000747	0.00158	CcSEcCtD
Apomorphine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000744	0.00157	CcSEcCtD
Apomorphine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000736	0.00156	CcSEcCtD
Apomorphine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000729	0.00154	CcSEcCtD
Apomorphine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000721	0.00188	CbGeAlD
Apomorphine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000715	0.00151	CcSEcCtD
Apomorphine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000711	0.00151	CcSEcCtD
Apomorphine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000698	0.00148	CcSEcCtD
Apomorphine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000688	0.00146	CcSEcCtD
Apomorphine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000684	0.00145	CcSEcCtD
Apomorphine—Headache—Etoposide—peripheral nervous system neoplasm	0.000674	0.00143	CcSEcCtD
Apomorphine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000663	0.0014	CcSEcCtD
Apomorphine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.0014	CcSEcCtD
Apomorphine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00065	0.00137	CcSEcCtD
Apomorphine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000639	0.00135	CcSEcCtD
Apomorphine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000629	0.00133	CcSEcCtD
Apomorphine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000629	0.00133	CcSEcCtD
Apomorphine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000627	0.00133	CcSEcCtD
Apomorphine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000613	0.0013	CcSEcCtD
Apomorphine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000608	0.00129	CcSEcCtD
Apomorphine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000603	0.00128	CcSEcCtD
Apomorphine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.00127	CcSEcCtD
Apomorphine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000593	0.00126	CcSEcCtD
Apomorphine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000583	0.00123	CcSEcCtD
Apomorphine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.00123	CcSEcCtD
Apomorphine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.00123	CcSEcCtD
Apomorphine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.00123	CcSEcCtD
Apomorphine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000564	0.00119	CcSEcCtD
Apomorphine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.00119	CcSEcCtD
Apomorphine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.00118	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000549	0.00116	CcSEcCtD
Apomorphine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.00116	CcSEcCtD
Apomorphine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000545	0.00115	CcSEcCtD
Apomorphine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.00114	CcSEcCtD
Apomorphine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000538	0.00114	CcSEcCtD
Apomorphine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000536	0.00113	CcSEcCtD
Apomorphine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000521	0.0011	CcSEcCtD
Apomorphine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00052	0.0011	CcSEcCtD
Apomorphine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000516	0.00109	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.00108	CcSEcCtD
Apomorphine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.00107	CcSEcCtD
Apomorphine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.00105	CcSEcCtD
Apomorphine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000497	0.00105	CcSEcCtD
Apomorphine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.00105	CcSEcCtD
Apomorphine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.00102	CcSEcCtD
Apomorphine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.00101	CcSEcCtD
Apomorphine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000973	CcSEcCtD
Apomorphine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000916	CcSEcCtD
Apomorphine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000903	CcSEcCtD
Apomorphine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000873	CcSEcCtD
Apomorphine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.000847	CcSEcCtD
Apomorphine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000844	CcSEcCtD
Apomorphine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000835	CcSEcCtD
Apomorphine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000811	CcSEcCtD
Apomorphine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000808	CcSEcCtD
Apomorphine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000799	CcSEcCtD
Apomorphine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000781	CcSEcCtD
Apomorphine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000758	CcSEcCtD
Apomorphine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000751	CcSEcCtD
Apomorphine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.00074	CcSEcCtD
Apomorphine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000701	CcSEcCtD
Apomorphine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	5.36e-05	0.000373	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.34e-05	0.000371	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.33e-05	0.00037	CbGpPWpGaD
Apomorphine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	5.32e-05	0.000369	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—NRAS—peripheral nervous system neoplasm	5.22e-05	0.000363	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.19e-05	0.00036	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.15e-05	0.000358	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.14e-05	0.000357	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.12e-05	0.000356	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.12e-05	0.000355	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.09e-05	0.000354	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—GNAS—peripheral nervous system neoplasm	5.07e-05	0.000352	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.06e-05	0.000351	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	5.04e-05	0.00035	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.02e-05	0.000349	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.02e-05	0.000349	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.01e-05	0.000348	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.98e-05	0.000346	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.98e-05	0.000346	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—ABCB1—peripheral nervous system neoplasm	4.97e-05	0.000345	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.94e-05	0.000343	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.91e-05	0.000341	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.85e-05	0.000337	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.77e-05	0.000332	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.77e-05	0.000331	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.75e-05	0.00033	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.62e-05	0.000321	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.6e-05	0.00032	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.54e-05	0.000316	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.54e-05	0.000315	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.52e-05	0.000314	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.45e-05	0.000309	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.4e-05	0.000305	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.38e-05	0.000304	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.36e-05	0.000303	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.33e-05	0.000301	CbGpPWpGaD
Apomorphine—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	4.28e-05	0.000297	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	4.24e-05	0.000295	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.24e-05	0.000294	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.21e-05	0.000292	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.19e-05	0.000291	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.17e-05	0.00029	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.15e-05	0.000289	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.12e-05	0.000286	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	4.12e-05	0.000286	CbGpPWpGaD
Apomorphine—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	4.09e-05	0.000284	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.08e-05	0.000283	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.07e-05	0.000283	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.05e-05	0.000281	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	4.04e-05	0.000281	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4e-05	0.000278	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	3.99e-05	0.000278	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.99e-05	0.000278	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.97e-05	0.000276	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.94e-05	0.000273	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.93e-05	0.000273	CbGpPWpGaD
Apomorphine—DRD5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.86e-05	0.000268	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.84e-05	0.000267	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.82e-05	0.000265	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	3.82e-05	0.000265	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.82e-05	0.000265	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.78e-05	0.000263	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.75e-05	0.000261	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.75e-05	0.000261	CbGpPWpGaD
Apomorphine—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	3.61e-05	0.000251	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.6e-05	0.00025	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.55e-05	0.000247	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.55e-05	0.000247	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.54e-05	0.000246	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.5e-05	0.000243	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.49e-05	0.000243	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.49e-05	0.000243	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.44e-05	0.000239	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	3.37e-05	0.000234	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	3.24e-05	0.000225	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.22e-05	0.000224	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.21e-05	0.000223	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.2e-05	0.000223	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.16e-05	0.000219	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.15e-05	0.000219	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.11e-05	0.000216	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	3.1e-05	0.000216	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.1e-05	0.000215	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.08e-05	0.000214	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.04e-05	0.000211	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.04e-05	0.000211	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.03e-05	0.00021	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3e-05	0.000208	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.98e-05	0.000207	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.97e-05	0.000207	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.97e-05	0.000206	CbGpPWpGaD
Apomorphine—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.95e-05	0.000205	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.95e-05	0.000205	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.94e-05	0.000205	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.93e-05	0.000203	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.93e-05	0.000203	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.9e-05	0.000201	CbGpPWpGaD
Apomorphine—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.89e-05	0.000201	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.87e-05	0.000199	CbGpPWpGaD
Apomorphine—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.85e-05	0.000198	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.82e-05	0.000196	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.8e-05	0.000194	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.79e-05	0.000194	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.76e-05	0.000192	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.76e-05	0.000192	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	2.74e-05	0.00019	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.72e-05	0.000189	CbGpPWpGaD
Apomorphine—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.72e-05	0.000189	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.69e-05	0.000187	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.68e-05	0.000186	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.68e-05	0.000186	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.67e-05	0.000186	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.64e-05	0.000183	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.63e-05	0.000183	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.63e-05	0.000182	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.6e-05	0.000181	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.6e-05	0.000181	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.58e-05	0.00018	CbGpPWpGaD
Apomorphine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.56e-05	0.000178	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.54e-05	0.000176	CbGpPWpGaD
Apomorphine—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.53e-05	0.000176	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.53e-05	0.000176	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.5e-05	0.000174	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.5e-05	0.000174	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.49e-05	0.000173	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.47e-05	0.000171	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.45e-05	0.00017	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.45e-05	0.00017	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.43e-05	0.000169	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.4e-05	0.000167	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.4e-05	0.000167	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.39e-05	0.000166	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.39e-05	0.000166	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.36e-05	0.000164	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.35e-05	0.000163	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.34e-05	0.000163	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.33e-05	0.000162	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.33e-05	0.000162	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.3e-05	0.00016	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.3e-05	0.00016	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.29e-05	0.000159	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.28e-05	0.000159	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.28e-05	0.000159	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.27e-05	0.000157	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.26e-05	0.000157	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.26e-05	0.000157	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.25e-05	0.000157	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.24e-05	0.000155	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.2e-05	0.000153	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.2e-05	0.000153	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.19e-05	0.000152	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.19e-05	0.000152	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.18e-05	0.000152	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.17e-05	0.000151	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.16e-05	0.00015	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.13e-05	0.000148	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.13e-05	0.000148	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.11e-05	0.000147	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.11e-05	0.000147	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.1e-05	0.000146	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.1e-05	0.000146	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.1e-05	0.000146	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.1e-05	0.000146	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.08e-05	0.000144	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.08e-05	0.000144	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.07e-05	0.000144	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.07e-05	0.000144	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2e-05	0.000139	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.99e-05	0.000138	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.99e-05	0.000138	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.98e-05	0.000138	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.96e-05	0.000136	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.96e-05	0.000136	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.96e-05	0.000136	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.94e-05	0.000135	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.93e-05	0.000134	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.92e-05	0.000133	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.91e-05	0.000132	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.9e-05	0.000132	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.9e-05	0.000132	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.89e-05	0.000131	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.89e-05	0.000131	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.88e-05	0.00013	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.84e-05	0.000128	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.83e-05	0.000127	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.82e-05	0.000126	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.81e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.79e-05	0.000125	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.78e-05	0.000124	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.77e-05	0.000123	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.77e-05	0.000123	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.76e-05	0.000122	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.76e-05	0.000122	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.74e-05	0.000121	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.73e-05	0.00012	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.73e-05	0.00012	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.73e-05	0.00012	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.73e-05	0.00012	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.72e-05	0.000119	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.7e-05	0.000118	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.7e-05	0.000118	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.65e-05	0.000115	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.65e-05	0.000115	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.63e-05	0.000113	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.62e-05	0.000113	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.61e-05	0.000112	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.61e-05	0.000112	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.61e-05	0.000112	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.58e-05	0.00011	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.58e-05	0.00011	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.57e-05	0.000109	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.56e-05	0.000108	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.55e-05	0.000108	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.54e-05	0.000107	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.54e-05	0.000107	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.53e-05	0.000106	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.5e-05	0.000104	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.47e-05	0.000102	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.46e-05	0.000101	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.45e-05	0.000101	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.44e-05	9.99e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.4e-05	9.72e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.39e-05	9.67e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.39e-05	9.63e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.37e-05	9.55e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	1.37e-05	9.5e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.36e-05	9.42e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.36e-05	9.42e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.35e-05	9.41e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.34e-05	9.31e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.34e-05	9.3e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.33e-05	9.26e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.33e-05	9.25e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.3e-05	9e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.27e-05	8.86e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.23e-05	8.54e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.22e-05	8.51e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.21e-05	8.4e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.18e-05	8.21e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.18e-05	8.17e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.18e-05	8.17e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.16e-05	8.03e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.14e-05	7.95e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.13e-05	7.82e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	1.11e-05	7.72e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.1e-05	7.64e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.05e-05	7.31e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.04e-05	7.21e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.02e-05	7.09e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.29e-06	6.45e-05	CbGpPWpGaD
